Cameron Tammy 4
4 · DEPOMED INC · Filed Jun 15, 2011
Insider Transaction Report
Form 4
DEPOMED INCDEPO
Cameron Tammy
VP, Finance
Transactions
- Exercise/Conversion
Common Stock
2011-06-14$3.09/sh+4,487$13,865→ 8,447 total - Exercise/Conversion
Stock Option
2011-06-14−1,354→ 27,083 totalExercise: $1.83Exp: 2019-01-23→ Common Stock (1,354 underlying) - Exercise/Conversion
Common Stock
2011-06-14$1.83/sh+1,354$2,478→ 5,314 total - Sale
Common Stock
2011-06-14$8.20/sh−4,487$36,801→ 3,960 total - Sale
Common Stock
2011-06-14$8.20/sh−17,493$143,474→ 3,960 total - Exercise/Conversion
Stock Option
2011-06-14−17,493→ 31,898 totalExercise: $3.09Exp: 2020-01-07→ Common Stock (17,493 underlying) - Sale
Common Stock
2011-06-14$8.24/sh−6,579$54,181→ 3,960 total - Sale
Common Stock
2011-06-14$8.20/sh−1,354$11,105→ 3,960 total - Exercise/Conversion
Common Stock
2011-06-14$3.09/sh+17,493$54,053→ 21,453 total - Exercise/Conversion
Stock Option
2011-06-14−4,487→ 16,122 totalExercise: $3.09Exp: 2020-01-07→ Common Stock (4,487 underlying)
Footnotes (3)
- [F1]Shares were initially purchased under Depomed, Inc.'s 2004 Employee Stock Purchase Plan.
- [F2]Exercisable in 48 equal monthly installments.
- [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.23 to $8.26. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.